Constitutive activation of T cells by γ2-herpesviral GPCR through the interaction with cellular CXCR4 by Kwon, E.-K et al.
Biochimica et Biophysica Acta 1864 (2017) 1–11
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbamcrConstitutive activation of T cells by γ2-herpesviral GPCR through the
interaction with cellular CXCR4Eun-Kyung Kwon a,b, Chan-Ki Min a,b, Yuri Kim a,b, Jae-Won Lee a,b, Abdimadiyeva Aigerim a,b,
Sebastian Schmidt a,b, Hyun-Jun Nam c, Seong Kyu Han c, Kuglae Kim d, Jeong Seok Cha d, Hoyoung Kim d,
Sanguk Kim c, Hyun-Soo Cho d, Myung-Sik Choi a, Nam-Hyuk Cho a,b,e,⁎
a Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
b Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea
c Department of Life Sciences, Pohang University of Science and Technology, Pohang 37673, Republic of Korea
d Department of Systems Biology, College of Life Science and Biotechnology, Yonsei University, Seoul 03722, Republic of Korea
e Institute of Endemic Disease, Seoul National University Medical Research Center and Bundang Hospital, Seoul 03080, Republic of Korea⁎ Corresponding author at: Seoul National University Co
ro, Jongno-gu, Seoul 03080, Republic of Korea.
E-mail address: chonh@snu.ac.kr (N.-H. Cho).
http://dx.doi.org/10.1016/j.bbamcr.2016.10.008
0167-4889/© 2016 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 11 July 2016
Received in revised form 14 September 2016
Accepted 11 October 2016
Available online 15 October 2016Members of the herpesviral family usemultiple strategies to hijack infected host cells and exploit cellular signal-
ing for their pathogenesis and latent infection. Among the most intriguing weapons in the arsenal of pathogenic
herpesviruses are the constitutively active virally-encoded G protein-coupled receptors (vGPCRs). Even though
vGPCRs contribute to viral pathogenesis such as immune evasion and proliferative disorders, the molecular de-
tails of how vGPCRs continuously activate cellular signaling are largely unknown. Here, we report that the
vGPCR of Herpesvirus saimiri (HVS), an oncogenic γ2-herpesvirus, constitutively activates T cells via a
heteromeric interaction with cellular CXCR4. Constitutive T cell activation also occurs with expression of the
vGPCR of Kaposi's sarcoma-associated herpesvirus (KSHV), but not the vGPCR of Epstein-Barr virus. Expression
ofHVS vGPCR down-regulated the surface expression of CXCR4 but did not induce the degradation of the chemo-
kine receptor, suggesting that vGPCR/CXCR4 signaling continues in cytosolic compartments. The physical associ-
ation of vGPCR with CXCR4 was demonstrated by proximity ligation assay as well as immunoprecipitation.
Interestingly, the constitutive activation of T cells by HVS vGPCR is independent of proximal T cell receptor
(TCR) signaling molecules, such as TCRβ, Lck, and ZAP70, whereas CXCR4 silencing by shRNA abolished T cell ac-
tivation by vGPCRs of HVS and KSHV. Furthermore, previously identiﬁed inactive vGPCR mutants failed to inter-
act with CXCR4. These ﬁndings on the positive cooperativity of vGPCR with cellular CXCR4 in T cell activation
extend our current understanding of themolecular mechanisms of vGPCR function and highlight the importance
of heteromerization for GPCR activity.
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CXCR41. Introduction
Herpesviruses are widespread mammalian pathogens that establish
lifelong latent infections, possibly via a long evolutionary history of spe-
ciﬁc interactionswith their host. Themembers of the herpesviral family
use multiple strategies to hijack infected host cells and exploit cellular
signaling to ensure successful infection and propagation. One of these
strategies includes encoding multiple regulatory viral proteins, such as
cytokines, chemokines, and viral G protein-coupled receptors (vGPCRs)
in their genomes. All the viral genomes of β- and γ-herpesviruses en-
code at least one vGPCR which is homologous to cellular chemokine re-
ceptor [1,2]. vGPCRs were probably derived from the host genomellege of Medicine, 103 Daehak-during evolution and modiﬁed to support various aspects of the viral
lifecycle, concomitant with viral pathogenesis such as immune evasion
and proliferative disorders. In contrast to host chemokine receptors,
which are activated in a ligand dependent manner and predominantly
couple to Gαi/o proteins, several vGPCRs are constitutively active and
can couple to multiple G proteins, thereby harnessing GPCR signaling
in host cells and organisms [1,2]. Since some naturally occurring, consti-
tutively active cellular GPCR variants have been shown to be associated
with diverse pathophysiological conditions in humans [3], the constitu-
tively active vGPCRs might play a crucial role in viral pathogenesis and
could be drug targets [2]. Indeed, constitutively active vGPCR of Kaposi's
sarcoma-associated herpesvirus (KSHV), a member of γ-Herpesvirus, is
causally associatedwith the initiation and progression of Kaposi's sarco-
ma [4,5]. KSHV vGPCR is capable of activating various signaling path-
ways, including the PI3K/AKT/mTOR axis for cellular proliferation [6,
7], and leads to the activation of cellular transcription factors such as
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shown to inhibit the progression of Kaposi's sarcoma [10]. Another
human γ-Herpesvirus, Epstein-Barr virus (EBV), also possesses a consti-
tutively active vGPCR, BILF1 [11]. EBV BILF1 can downregulate MHC-I/
peptide complexes [12] and block the phosphorylation of RNA-
dependent protein kinase (PKR) [13], thereby suppressing host antiviral
responses. Therefore, γ-Herpesviral vGPCRs may confer diverse advan-
tage in viral replication and dissemination during the life-long infection
in a host. However, the molecular and structural details of how vGPCRs
initiate and activate G-protein-coupled signaling remain largely un-
known [1].
Herpesvirus saimiri (HVS) is a T cell lymphotropic virus and the pro-
totype of the oncogenic γ2-herpesviruses (or rhadinoviruses), which
also includes the human viral homologue, KSHV [15]. HVS, which
were classiﬁed into three subgroups A, B, and C [16], is apathogenic in
its natural host, the squirrel monkey, whereas experimental infection
of HVS, especially subgroup C strains, in various primate species and
rabbits causes acute and fatal T cell lymphoma [15]. In addition, HVS
subgroup C strains can transform human T cells to continuously prolif-
erate in vitro in the absence of antigenic or mitogenic stimulation [17].
Therefore, HVS has been considered as a good model system to study
the mechanisms for transforming and pathogenic capability as well as
apathogenic persistence of γ-herpesviruses in the host [15]. Similar to
other γ-herpesviruses, HVS harbors various host cell modulatory
genes, including a vGPCR [18]. Previously, it was reported that HVS
vGPCR activates a broad range of signaling pathways through multiple
G proteins [19]. However, the functional role of HVS vGPCR in viral path-
ogenesis and/or natural latency has been poorly deﬁned, especially in T
cells.
In this study, we investigated functional phenotypes of T cells ex-
pressing HVS vGPCR and found that the vGPCR can constitutively and
potently activate T cells. Surprisingly, constitutive activation of T cells
by the HVS vGPCR is independent of proximal T cell receptor (TCR) sig-
naling molecules, such as TCRβ chain, Lck, and ZAP70, but requires a
physical interaction with cellular CXCR4. We also show that HVS
vGPCR constitutively down-regulates the chemokine receptor from
the surface and sequesters it in the intracellular compartments. Al-
though itwas shown that vGPCRof EBV, aγ1-herpesvirus, physically in-
teracts with CXCR4 and consequently inhibits CXCR4 signaling
potentially via scavenging Gαi proteins [20], our unexpected ﬁndings
on the positive cooperativity of HVS vGPCR with cellular CXCR4 in T
cell activation shed light on the function of hetero-dimerization of
vGPCR. In addition, the functional phenotypes induced by HVS vGPCR
were reproducibly observed by KSHV vGPCR, but not by EBV vGPCR,
suggesting that the functional activity of vGPCR is evolutionary con-
served solely in γ2-herpesviruses. These results may not only provide
new insight into the molecular basis of vGPCR in viral pathogenesis of
γ2-herpesviruses but also open new avenues for studying the intermo-
lecular interactions between GPCRs that lead to the activation of cellular
signaling.
2. Materials and methods
2.1. Ethnics statement
Ethnical approval for using human peripheral bloodmonocytes from
healthy volunteers was granted by the Institutional Review Board of
Seoul National University Hospital (IRB No. C-1412-089-634) and all
the experiments were carried out in accordance with the approved
guidelines. All the healthy volunteers provided written informed con-
sent prior to blood collection.
2.2. Cell culture and stimulation
Cultures of Human embryonic kidney (HEK) 293 T cells and HeLa
cells were grown inDulbecco'smodiﬁed Eagle'smedium supplementedwith 10% fetal bovine serum and 1% penicillin and streptomycin. Jurkat
T and SupT-1 cells were grown in RPMI 1640 supplemented with 10%
fetal bovine serum and 1% penicillin and streptomycin, respectively.
J.RT3-T3.5 (ATCC, TIB-153), J.CaM1.6 (ATCC, CRL-2063), P116 (ATCC,
CRL-2676), and J.gamma1 (ATCC, CRL-2678) cells, which have deﬁcient
expression of TCRβ, Lck, ZAP70, and PLCγ1, respectively, were obtained
from ATCC (www.atcc.org) and maintained in the same manner as
Jurkat T cells. Speciﬁc deﬁciency of the indicated signaling proteins
was conﬁrmed by immunoblot using speciﬁc antibodies and whole
cell lysates derived from themutant cells (Supplementary Fig. S1). Lipo-
fectamine2000 (Invitrogen) or calcium phosphate (Clontech) was used
for transient expression of vGPCRs or CXCR4 in HeLa or 293T cells. Elec-
troporation using a Bio-Rad electroporator (260 V, 975 μF) or Neon
Transfection System (Invitrogen, 2150 V, 20 ms) was used for transient
expression of vGPCR in Jurkat and SupT-1 cells. For TCR stimulation,
Jurkat cells were incubated with anti-CD3/CD28 coated Dynabeads
(ThermoFisher Scientiﬁc) for 18 h at 37 °C. In order to examine the ef-
fect of AMD3100 (Sigma-Aldrich), a CXCR4 antagonist, on the activation
of T cells by vGPCR, Jurkat T cells were pre-incubated with 10 μM of
AMD3100 for 30 min, and then cells were transduced with lentiviral
vectors encoding vGPCR. Jurkat cells expressing vGPCR were analyzed
for cellular activation after 24 h of incubation in the presence of
AMD3100. Primary T lymphocytes were isolated from human peripher-
al blood mononuclear cells (PBMCs) by negative selection using the
Miltenyi magnetically activated cell sorter (MACS) with pan T isolation
kit (Miltenyi Biotec) and cultured in RPMI supplemented with 20% fetal
bovine serum at a density of 1 × 106 cells/ml. Primary T lymphocytes
were electroporated using Neon Transfection System (2150 V, 20 ms).
2.3. Plasmids and lentiviral vector
All the gene constructs for transient and stable expression in mam-
malian cells were cloned into pDEF3 GST [21], pHJEF IRES eGFP [22],
pmCherry-C1 (Clontech), or pEF1α-IRES-Puro (Clontech). cDNAs
encoding Human CXCR4 and EBV vGPCR were obtained from Addgene.
HVS vGPCR was cloned from a HVS Bacmid clone (BAC43) which was
kindly provided by Dr. Armin Ensser. Plasmid constructs encoding
KSHV vGPCRwere kindly provided by Dr. Pinghui Feng. The cDNA frag-
ments containing full-length or mutant vGPCRs were sub-cloned into
pHJEF IRES eGFP vector after PCR-based site-directed mutagenesis.
The recombinant lentiviruses were obtained by co-transfection of
lentiviral plasmids together with packaging vector psPAX2 and enve-
lope vector pMD2.G into 293T cells. Cell culture supernatants containing
the virus were collected at 48 h after transfection and used for lentiviral
transduction.
2.4. Reporter assays
293T cells were transfected with plasmids encoding vGPCR together
with theNFAT, AP-1, orNF-κB luciferase reporter plasmids (Stratagene).
Plasmid encoding Renilla luciferase (pRL-CMV, Promega) was co-
transfected as an internal control to evaluate transfection efﬁciency. At
48 h post-transfection, cells were washed once in ice-cold PBS and
lysed in 200 μl of 1 × passive lysis buffer. Luciferase activity was assayed
using the dual luciferase assay kit (Promega) according to the
manufacturer's instructions. Luminescence was measured with 96 mi-
croplate luminometer (DTX880, Beckman Coulter Inc.) and normalized
with Renilla luciferase activity.
2.5. Measurements of secreted IL-2
GFP-positive Jurkat cells transduced with lentiviral vector encoding
vGPCRwere sorted and incubated for 48 h. IL-2 secretion in the cell cul-
ture medium was measured with an enzyme-linked immunosorbent
assay kit (PharMingen) according to the manufacturer's instruction.
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Cells were washed with ice-cold ﬂuorescence activated cell sorter
(FACS) buffer (PBS containing 1% bovine serum albumin (BSA) and
1 mM EDTA), ﬁxed with 4% paraformaldehyde, and subsequently
stained with the following antibodies for 30 min at 4 °C: APC/Cy7-
conjugated anti-CD69 (clone FN50, eBiosciences), PE/Cy7-conjugated
anti-TCRαβ (clone IP26, eBiosciences), PerCP-Cy5.5-conjugated
anti-CD4 (clone OKT4, eBiosciences), APC-conjugated anti-CXCR4
(clone 12G5, eBioscience), PE-conjugated anti-CD45 (clone HI30,
BD Pharmingen), and PE-conjugated anti-CD25 (clone M-A251, BD
pharmingen). For staining whole cellular CXCR4, cells were stained
with APC-conjugated anti-CXCR4 antibodies, or isotype controls
after ﬁxation and perameabilization using Cytoﬁx/Cytoperm solu-
tion (BD Biosciences). The cells were analyzed using a FACS Canto II
ﬂow cytometer (BD Biosciences). Data were analyzed by FlowJo soft-
ware version 8.8.6 (FlowJo).
2.7. Immunoﬂuorescence analysis and proximity ligation assay (PLA)
The cells were ﬁxed with 4% paraformaldehyde in PBS for 15 min at
room temperature, and then permeabilized with 0.2% Triton X-100 for
15 min. After blocking with 5% BSA in PBS, the cells were incubated
with mouse anti-Flag M2 (for vGPCR, Sigma) and rabbit anti-CXCR4
(clone 12G5, Abcam) antibody at 4 °C for 16 h in a humidifying cham-
ber. Alexa488- or Alexa594-conjugated anti-mouse and anti-rabbit IgG
antibodies (Molecular Probes) were used as secondary antibodies. A
proximity ligation assay kit (Olink Bioscience Ltd.) was used to detect
co-localization of vGPCR and endogenous CXCR4 in situ according to
the manufacturer's instruction. Confocal microscopy was performed
using an OlympusFV1000 laser-scanning microscope (Olympus). All
images were analyzed and processed using the Olympus Fluoview or
Adobe Photoshop software.
2.8. Pull-down assay, co-immunoprecipitation, and immunoblotting
Glutathione S-transferase (GST) pull-down assay was performed
using lysate of Jurkat cells electroporated with pDEF3/vGPCR-GST con-
struct [23]. In brief, 1 × 108 cellswere harvested and lysed inNP-40 buff-
er (50 mM Tris–HCl [pH 7.4], 150 mM NaCl, 1% NP-40, 5 mM EDTA)
supplemented with a protease inhibitor cocktail (Roche). Post-
centrifuged supernatants were precleared with protein A/G beads
(Santa cruz) at 4 °C for 2 h and then incubated with 50% slurry of
glutathione-conjugated sepharose beads (Amersham Biosciences) at
4 °C for 4 h. Precipitates were washed extensively with lysis buffer. Pro-
teins bound to glutathione beads were eluted with SDS-PAGE sample
buffer after boiling at 70 °C for 5 min. For immunoprecipitation assay,
293T cells transfected with the indicated plasmids were harvested and
lysed in 1 ml of RIPA buffer (50 mM Tris/HCl [pH 7.5], 150 mM NaCl,
1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS). The whole cell lysates
were pre-cleared by centrifugation (15,000 ×g, 4 °C for 10 min) and
then incubated with the indicated antibody and protein A/G-agarose
beads at 4 °C overnight with gentle rotation. The immunocomplex
was collected by centrifugation, washed 3 times with a buffer (0.1% Tri-
ton X-100, 50 mM Tris–Cl [pH 7.5], 150 mM NaCl, 1 mM EDTA), eluted
with 2× Laemmli sample buffer, and subjected to SDS-PAGE. Antibodies
used in immunoblot analysis were as follows: mouse anti-FLAG M2
(Sigma), rabbit anti-CXCR4 polyclonal antibody (Abcam), goat anti-
AU1-polyclonal antibody (Bethyl Laboratories), mouse anti-β-actin
monoclonal antibody (Santa cruz), mouse anti-GAPDH monoclonal an-
tibody (Calbiochem), rabbit anti-GST polyclonal antibody (Santa cruz),
mouse anti-p38 monoclonal antibody (Santa cruz), mouse anti-
phospo-p38monoclonal antibody (Santa cruz), rabbit anti-PLCβ3 poly-
clonal antibody (Santa cruz), rabbit anti-phopho-PLCβ3 polyclonal anti-
body (Santa cruz), rabbit anti-Akt polyclonal antibody (Cell Signaling),
rabbit anti-phospho-Akt polyclonal antibody (Cell Signaling), mouseanti-p44/42 MAPK (Erk1/2) monoclonal antibody (Cell Signaling),
mouse anti-phospho-p44/42 MAPK (Erk1/2) monoclonal antibody
(Cell Signaling), mouse anti-TCRβ (Thermo Scientiﬁc), mouse anti-Lck
(Santa Cruz), rabbit anti-ZAP70 (Cell Signaling), and rabbit anti-PLCγ1
(Cell Signaling). Detection of protein bands was performed by using
an enhanced chemiluminescence system (Pierce).
2.9. Measurement of intracellular calcium
Jurkat cells expressing vGPCRwere loaded with Fluo-4AM (Molecu-
lar Probes) for 30 min at 37 °C. Cells were then washed and further in-
cubated with fresh medium for 20 min. Live cells were analyzed with
a FACS Canto II ﬂow cytometer (BD Biosciences) and the ﬂuorescence
signal was quantiﬁed via FlowJo software version 8.8.6 (FlowJo).
2.10. CXCR4 knock-down in Jurkat cells
CXCR4-knockdown (K/D) in Jurkat cells was performed using a len-
tivirus system encoding shCXCR4 (clone ID., V2LHS_172391, Open
Biosystems). The target sequence(ACAGCAACTAAGAACTTGG, located
in 3′ untranslated region) of human CXCR4 was inserted into pGipz
lentiviral vector. Lentiviruses were produced by transient transfection
using packaging plasmids (psPAX2 and pMD2.VSV-G purchased from
Addgene) after calcium phosphate-mediated transfection into 293T
cells. Virus containing media were collected at 72 h post-transfection
and used for transduction after passing the supernatants through
a 0.45 μm ﬁlter. Nonsilencing-pGipz lentiviral shRNAmir control
(RHS4346, Open Biosystems) construct was used as a negative control.
Viral transduction was assessed by GFP expression and the transduced
cells were selected by 2 μg/ml puromycin (Sigma-Aldrich). Stable
knockdown of CXCR4 was conﬁrmed by FACS analysis and immuno-
blotting for CXCR4.
2.11. Statistical analysis
Statistical analyses were performed using an unpaired two-tailed
Student's t-test or one-way ANOVA with GraphPad Prism 6.0 software
(GraphPad Software Inc.). Data are presented as the mean ± standard
deviation. Statistical signiﬁcance is deﬁned at the p b 0.05 level.
3. Results
3.1. Constitutive activation of cellular signaling by γ2-herpesviral GPCRs
In order to conﬁrm the constitutive activity of HVS vGPCR, we per-
formed reporter assays driven by NFAT, AP-1, and NF-κB transcription
factors in 293T cells (Fig. 1A). HVS vGPCR actively enhanced NFAT and
AP-1-dependent gene expression in 293T cells in dose-dependentman-
ner, but failed to induce the NF-κB-dependent reporter. It activated
NFAT-mediated transcription as efﬁciently as KSHV vGPCR, which is
highly and constitutively active [8,24], whereas its effect on AP-1-
dependent transcription was relatively weaker than KSHV vGPCR. We
further conﬁrmed the activation of cellular signaling by HVS vGPCR in
293T cells and Jurkat cells by immunoblot (Fig. 1B). Transient overex-
pression of HVS vGPCR in both 293T and Jurkat cells induced phosphor-
ylation of PLC-β, p38MAP kinase, and AKT as efﬁciently as KSHV vGPCR
did. Phosphorylation of ERK by HVS vGPCR expression was observed in
Jurkat cells but not in 293T cells. Differential activation of ERK by KSHV
vGPCR in a cell-type dependent manner has been previously reported
[25]. Since activation of NFAT transcription factor is primarily mediated
by the increased intracellular calcium, we also assessed cytosolic calci-
um with a ﬂuorescent probe in Jurkat cells expressing HVS vGPCR. As
expected, vGPCR expression increased cytosolic calcium level by 1.6
fold, compared to control cells (Fig. 1C and D). These results clearly
show that HVS vGPCR, like KSHV vGPCR, is capable of constitutively ac-
tivating cellular signaling.
Fig. 1.HVS vGPCR constitutively activates cellular signaling. (A) 293T cells were transfectedwith the indicated reporter plasmid and increasing amounts of plasmid encoding HVS vGPCR.
Activation of transcription factorswas assessed by luciferase reporter assays. KSHV vGPCRwas usedas thepositive control. Eachassaywas performed in triplicate and data are expressed as
the mean + standard deviation. Representative immunoblots showing vGPCR expression and β-actin, as a loading control, are presented in the bottom panels. (B) Whole cell lysates of
293T cells or Jukat cells expressing vGPCR were analyzed by immunoblotting with antibodies against the indicated signaling proteins. Relative position of a molecular weight marker is
indicated in each immunoblot. (C) and (D) Jurkat cells electroporated with HVS vGPCR fused with mCherry were loaded with Flor-4-AM and ﬂuorescent intensities of mCherry-
positive cells were quantiﬁed by ﬂow cytomeric analysis at 48 h after electroporation. Mean ﬂuorescent intensities of Flor-4-AM were presented within mCherry-positive gates (C).
Each assay was performed in triplicate and data are expressed as the mean + standard deviation (D). **, p b 0.01.
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To investigate and compare the effect of γ-herpesviral vGPCRs on T
cells, Jurkat cells were electroporated or lentivirally-transduced with
plasmids encoding vGPCRs from HVS, KSHV, or EBV and CD69 surface
expression was measured as an indicator of T cell activation. Expression
of vGPCRs from HVS or KSHV, but not from EBV, signiﬁcantly enhanced
CD69 expression when compared to those of untransfected or vector-
transfected cells (Fig. 2A and B, Supplementary Fig. S2). Activation of
Jurkat cells by HVS or KSHV vGPCR was further conﬁrmed by detection
of IL-2 secretion (Fig. 2D) and elevation of IL-2 receptor α chain, CD25,
on the surface (Supplementary Fig. S3). In addition to the T cell activa-
tion markers, we also examined other T cell receptors including TCR
and CD4 and a chemokine receptor, CXCR4. Surface levels of TCR, CD4
as well as CXCR4were substantially down-regulated in cells expressing
vGPCR of HVS or KSHV, whereas expression of EBV vGPCR induced
downregulation of CXCR4 but not TCR and CD4 (Supplementary
Fig. S4 and Fig. 2A and B). Marginal changes in surface expression of
CD45 were observed in cells expressing vGPCRs. In order to conﬁrm
the effect of vGPCRs on T cell activation, CD3+ primary T cells puriﬁed
from human PBMCs were electroporated with empty vector or plasmid
encodingHVS vGPCR (Fig. 2D and E). Interestingly, activation of primary
T cells, asmeasured by CD69 surface expression, was observed only in a
fraction of cellswhere surface expressionof CXCR4was down-regulated(Fig. 2D). This negative correlation of CXCR4 down-regulation and
CD69 up-regulation was also observed in Jurkat cells expressing
vGPCRs of HVS or KSHV (Supplementary Fig. S2B). Cellular activation
was reproducibly observed in another T cell line, SupT1 cells, by ex-
ogenous expression of HVS or KSHV vGPCRs, but not by EBV vGPCR
(Supplementary Fig. S4C and S4D). Surface expression of CXCR4
was also down-regulated in SupT1 cells expressing vGPCRs. These
results clearly indicate that expression of HVS or KSHV vGPCR can in-
duce cellular activation of T cells, but EBV vGPCR failed to do so. In
addition, changes in surface expression of CXCR4 or TCR/CD4 mole-
cules in T cells suggest a potential link of those receptors with cellu-
lar activation by vGPCRs.
3.3. Upstream T cell receptor signaling complex is not required for cellular
activation by HVS vGPCR
Since we observed concurrent downregulation of TCR and CD4mol-
ecules in T cells by vGPCR expression, we next assessed the role of up-
stream TCR signaling components in T cell activation by using mutant
Jurkat cell lines. Jurkat cell lines harboring mutations in TCRβ chain
(J.RT3-T3.5), Lck (J.CaM1.6), ZAP70 (P116), or PLCγ1 (J.gamma1),
were electroporated with empty vector or plasmid encoding HVS
vGPCRand cellular activationwas examinedbymeasuringCD69 surface
expression. As seen in Fig. 3, expression of HVS vGPCR in themutant cell
Fig. 2. HVS vGPCR constitutively activates T cells. (A) Jurkat cells were electroporated with pEF1α-IRES-eGFP plasmid encoding the indicated vGPCR and the surface level of cellular
markers were analyzed in GFP-positive cells by ﬂow cytometry at 48 h after electroporation. Mean ﬂuorescent intensities of indicated markers were presented within GFP-positive
gates. (B) Surface expression of the indicated cellular markers was quantitated from triplicate experiments in Jurkat cells expressing vGPCRs. Data are presented as the mean +
standard deviation. (C) Production of IL-2 from Jurkat cells expressing vGPCRs was assessed by ELISA at 48 h after transduction with lentiviral vectors encoding the indicated vGPCR.
This assay was performed in triplicate and data are presented as the mean + standard deviation. (D) Primary T cells isolated from human PBMCs were electroporated with pEF1α-
IRES-eGFP plasmid encoding HVS vGPCR and the surface levels of cellular markers were analyzed in GFP-positive cells by ﬂow cytometry at 48 h after electroporation. Gating strategy
is presented in the upper panels. (E) Surface expression of the indicated cellular markers was quantitated from triplicate experiments in primary T cells expressing HVS vGPCR. Data
are presented as the mean + standard deviation. **, p b 0.01 when compared to vector control.
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gardless of the mutations, indicating that the proximal components of
early T cell receptor signaling are not required for T cell activation by
HVS vGPCR. Interestingly, surface expression of CXCR4 was drastically
down-regulated in the mutant cell lines upon vGPCR expression. In
the absence of PLCγ1, however, the level of CD69 surface expression is
lower than that of the other mutant cell lines, suggesting that PLCγ1
might be partially involved in the activation signaling mediated by
vGPCR expression.
3.4. Involvement of CXCR4 in T cell activation by HVS vGPCR
Expression of vGPCRs in T cells not only induced T cell activation but
also down-regulated surface expression of CXCR4. In addition, it was
reported that herpesviral vGPCRs physically interact with cellular che-
mokine receptors including CXCR4 [1]. Therefore, we analyzed the po-
tential role of cellular CXCR4 in T cell activation by HVS vGPCR. First,
we examined whether HVS vGPCR physically interacts with CXCR4. As
seen in Fig. 4A, vGPCR speciﬁcally interacted with cellular CXCR4 in
GST-pull down assays. In addition, overexpressed HVS vGPCR primarily
co-localized with cellular CXCR4 in both HeLa and Jurkat cells in intra-
cellular compartments (Fig. 4B), indicating that they interact in vivo.
The speciﬁc interaction of vGPCR and endogenous CXCR4 was further
conﬁrmed by an in situ proximity ligation assay (Fig. 4C) [26]. Basedon the microscopic imaging assay, most CXCR4 complexed with
vGPCR is localized in the cytoplasm, suggesting that interaction with
vGPCR may induce endocytosis of CXCR4 or inhibit its trafﬁcking to
the cellular surface. When we examined the total protein level of
CXCR4 in vGPCR-expressing Jurkat cells, therewasno signiﬁcant change
in the amount CXCR4 with vGPCR expression (Supplementary Fig. S5).
Therefore, expression of vGPCR in T cells may affect intracellular
trafﬁcking of CXCR4 via a physical interaction and thereby reduce its
surface expression without signiﬁcantly changing the protein level
of the chemokine receptor. To investigate the functional role of CXCR4
in vGPCR-mediated T cell activation, we established a CXCR4-
knockdown (K/D) Jurkat T cell line by using lentiviral shRNA targeting
cellular CXCR4 and characterized it. Knockdown of surface expression
as well as protein expression of CXCR4 was conﬁrmed in the CXCR4 K/
D Jurkat cells (Fig. 5A). CXCR4 K/D in Jurkat cells slightly enhances sur-
face expression of TCR/CD3 molecules but does not signiﬁcantly affect
activation status as measured by CD69 expression (Supplementary
Fig. S6) nor did it affect viability (data not shown). Although slightly de-
creased when compared to that of control cells, CXCR4 K/D Jurkat cells
were also efﬁciently activated by stimulation with anti-CD3/CD28 coat-
ed beads, suggesting that their TCR signaling pathway remains intact
(Supplementary Fig. S7). However, overexpression of HVS vGPCR
tagged with mCherry severely impaired cellular activation in CXCR4
K/D cells compared to control cells (Fig. 5B and C). Similar results
Fig. 3. Activation of T cells by HVS vGPCR is independent of proximal T cell signaling components. (A) Mutant Jurkat cell lines deﬁcient in the indicated signaling molecules were
electroporated with pEF1α-IRES-eGFP plasmid encoding HVS vGPCR and the surface levels of cellular markers were analyzed in GFP-positive cells by ﬂow cytometry at 48 h after
electroporation. (B) Surface expression of the indicated cellular markers was quantitated from triplicate experiments in the cell lines expressing HVS vGPCR. Data are presented as the
mean + standard deviation. **, p b 0.01 when compared to vector control.
Fig. 4.HVS vGPCR interactswith cellular CXCR4. (A) Jurkat cellswere electroporatedwith a plasmid encodingGST or GST-vGPCR and cellular lysateswere applied for GST-pulldown assay.
Interaction of vGPCR with cellular CXCR4 was assessed by immunoblot using an anti-CXCR4 antibody. Relative position of a molecular weight marker is indicated in each immunoblot.
(B) HeLa and Jurkat cells expressing ﬂag-tagged vGPCR were co-stained with antibodies against ﬂag-tag (red) and cellular CXCR4 (green) and observed under confocal microscopy
(right panels). Endogenous expression of CXCR4 in cells harboring empty vector was shown in left panels as control. White bar, 10 μm. (C) Jurkat cells electroporated with empty
vector or plasmids encoding HVS vGPCR were analyzed after proximity ligation assay. Cells were stained with the speciﬁc antibody pairs against CXCR4 and ﬂag and visualized by
confocal microscopy. Representative image showing the signal (red) from the proximity ligation assay were presented. White bar, 10 μm.
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Fig. 5. CXCR4 silencing inhibits T cell activation by HVS vGPCR. (A) CXCR4 knockdownwas performed using lentiviral vector encoding shRNA targeting CXCR4 and the surface expression
(upper panels) and protein level (lower panels) of CXCR4 in the established Jurkat cell lines were analyzed by ﬂow cytometry and immunoblot, respectively. Relative position of a
molecular weight marker is indicated in each immunoblot. (B) CXCR4 knockdown Jurkat cells were electroporated with a plasmid encoding vGPCR fused with mCherry and the
surface expression level of CD69 was assessed in mCherry-positive cells by ﬂow cytometry at 48 h after the electroporation. Gating strategy is presented in the upper panels.
(C) Surface expression of CD69 was quantitated from triplicate experiments in cells used in (B). Data are presented as the mean + standard deviation. **, p b 0.01 when compared to
vector control.
7E.-K. Kwon et al. / Biochimica et Biophysica Acta 1864 (2017) 1–11were reproduced in CXCR4 K/D cells expressing KSHV vGPCR (Supple-
mentary Fig. S8). In order to conﬁrm whether complementation of
CXCR4 could recover vGPCR-mediated T cell activation in CXCR4 K/D
cells, cells were electroporated with plasmids encoding CXCR4 and
HVS vGPCR tagged with mCherry. Expression of vGPCR-mCherry to-
gether with CXCR4 in CXCR4 K/D cells signiﬁcantly enhanced CD69 ex-
pression (Supplementary Fig. S9). Taken together, these results indicate
that expression of CXCR4 is required for T cell activation by HVS and
KSHV vGPCRs.
3.5. Functional correlation of CXCR4 interaction with T cell activation by
HVS vGPCR mutants
Constitutive activation of cellular signaling by vGPCR of KSHV is af-
fected by severalmutations at speciﬁc amino acid residues near orwith-
in the transmembrane domains as well as in its cytoplasmic C-terminus
[27–29]. In order to further conﬁrmwhether constitutive activation of T
cells by HVS vGPCR in the absence of ligand correlates with its interac-
tion with CXCR4, we generated several speciﬁc point mutations at
amino acid residues conserved in both HVS and KSHV vGPCRs, which
have been shown to abolish constitutive activity of KSHV vGPCR with-
out inﬂuencing vGPCR expression (Supplementary Fig. S10) [27–29].
The levels of expression of the mutant vGPCRs in Jurkat cells were not
signiﬁcantly different from those of wild type vGPCR (Fig. 6). Two mu-
tations in transmembrane II of HVS vGPCR, L83D and L86D, which are
equivalent to L91D and L94D mutations in KSHV vGPCR, respectively
[27], failed to activate T cells and downregulate CXCR4 from the surface
(Fig. 6A). In addition, the two mutant proteins did not interact with
CXCR4 (Fig. 6B). L91D and L94D substitutions in KSHV vGPCR were
shown to abolish its constitutive activity, while preserving its ability tobe stimulated by an agonist, GROα [27]. One more mutant, R134A of
HVS vGPCR (which is the equivalent of R143A in KSHV vGPCR, see Sup-
plementary Fig. S9) [28], showed a phenotype similar to the L83D and
L86Dmutantswhen expressed in T cells (Fig. 6). The R143A substitution
in KSHV vGPCR was shown to abolish its constitutive activity and re-
sponsiveness upon stimulation with GROα [28]. Another mutant,
D75A of HVS vGPCR, the equivalent of D83A in KSHV vGPCR (Supple-
mentary Fig. S9) [28], showed a similar level of T cell activation and
CXCR4 downregulation as in wild type, and retained its ability to
interact with CXCR4 (Fig. 6). It was shown that the D83A substitution
in KSHV vGPCR could stimulate signaling activity 190% above wild
type vGPCR, but poorly was stimulated by GROα [28]. A string of
amino acids in the C-terminus of vGPCR is highly conserved in γ2-
herpesviruses and is also involved in constitutive activation of G-
protein mediated cellular signaling [29]. Therefore, we also generated
mutations in the conserved C-terminus and investigate their effects on
T cell activation as well as CXCR4 interaction. Deletion of the cytoplas-
mic C-terminus (Δ309–321) in HVS vGPCR abolished constitutive acti-
vation of T cells (Fig. 7A–C). The conserved QRM residues might be
critical for T cell activation by vGPCR since partial deletion of the QRM
sequence from the C-terminus (Δ309–314) failed to activate T cells,
while partial deletion of the sequence beyond the conserved motif
(Δ315–321) retained the ability for constitutive activation. Therefore,
we next generated QRM/AAA or M311G mutations to further deﬁne
the speciﬁc role of the amino acid residues in T cell activation (Fig. 7D
and F). As reported in a previous study using KSHV vGPCR [29], muta-
tions in cytoplasmic QRM or M311 residues in HVS vGPCR abrogated
or dramatically reduced the constitutive activity of vGPCR. Moreover,
the substitutions also abolished or diminished its interaction with
CXCR4 (Fig. 7F). Taken together, these results showing that all point
Fig. 6. Inactive mutant vGPCRs fail to interact with CXCR4. (A) Jurkat cells were
electroporated with plasmids encoding wild type vGPCR or inactive mutants and
examined for the surface expressions of cellular markers in triplicate experiments. Data
are presented as the mean + standard deviation. **, p b 0.01 when compared to vector
control. (B) 293T cells were transfected with plasmid encoding wild type vGPCR or the
indicated mutants, together with a plasmid encoding CXCR4. Cellular lysates were
precipitated with anti-ﬂag antibody (vGPCRs) and applied for immunoblot with the
indicated antibodies. Relative position of a molecular weight marker is indicated in each
immunoblot.
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CXCR4 strongly suggest that HVS vGPCR interactionwith cellular CXCR4
is functionally linked to its constitutive activation of T cells.
4. Discussion
Since the discovery of the presence of three viral genes encoding ho-
mologs of cellular GPCRs in the genome of human cytomegalovirus
(HCMV) in 1990 [30], vGPCRs have been identiﬁed in a number of β-
and γ-herpesviruses as well as poxviruses [31]. vGPCRs are most ho-
mologous to chemokine receptors among host GPCR family members
and appear to be exploited by the viruses for various pathogenic func-
tions such as viral spread, immune evasion, and oncogenesis [31,32].
Orf74 of Herpesvirus saimiri is a homolog of host CXCR2 [33] and the
ﬁrst viral vGPCR identiﬁed in oncogenic γ-herpesviruses [18]. Even
though EBV and KSHV vGPCRs have been extensively characterized for
their pathogenic roles in viral immune evasion and oncogenesis [2,32],
the role of HVS vGPCR in viral pathogenesis remains poorly deﬁned
[19,33]. In addition, the effect of HVS vGPCR on cellular signaling in T
cells has never been assessed even though HVS is a lymphotropic
rhadinovirus (γ2-herpesvirus), like KSHV, and can cause fulminant T-
cell lymphoma in non-natural host primates and transform human T
cells in vitro [15]. Therefore, in the current study, we investigated the
potential mechanisms exploited by HVS vGPCR in host T cells.
In a previous study, HVS vGPCRwas shown to constitutively activate
cellular signaling through Gαi and/or Gα12/13, but not through Gαq [19].
The preferential activation of G protein subtypes by HVS vGPCR was
validated by use of speciﬁc inhibitors such as pertussis toxin andC3 exo-
enzyme, which inhibit Gαi- and Gα12/13-dependent signaling, respec-
tively. It was also reported that the vGPCR constitutively increased
transcriptional activation of serum response element in 293T cells, but
failed to induce the activity of cAMP response element-binding protein,NFAT, and NF-κB, which were only up-regulated in a ligand-dependent
manner [19]. However, constitutive activation of NFAT-dependent tran-
scription by HVS vGPCRwas reproducibly observed in our experiments.
In the previous study, Rosenkilde et al. used up to 50 ng (per 35,000
cells/96 well) of plasmid encoding vGPCR to show inducible activation
of transcription factors by several vGPCR agonists [19], whereas we
used up to 1000 ng (per 200,000 cells/24 well) of DNAs since we
could not observe signiﬁcant activation of the reporter system when
the lower concentration of DNAs was used. Despite the discrepancy in
the activation of NFAT transcription factor by HVS vGPCR in 293T cells,
its potent activation of T cells, as measured by CD69 and CD25 upregu-
lation aswell as by IL-2 secretion, strongly suggests that it can stimulate
cellular signaling mediated by NFAT in cooperation with AP-1, the pri-
mary transcriptional regulators of T cell activation [34]. Upstream sig-
naling for NFAT activation includes the stimulation of phospholipase C
(PLC), an enzyme that catalyzes the formation of inositol 1,4,5-triphos-
phate (IP3) and diacylglycerol (DAG) from phosphatidylinositol-4,5-
bisphosphate (PIP2). IP3 in turn activates the IP3 receptor (IP3R) on
the endoplasmic reticulum (ER) to increase intracellular Ca2+ levels,
resulting in activation of calcineurin phosphatase that dephosphory-
lates multiple phosphoserines on NFAT, leading to its nuclear transloca-
tion and activation [34]. GPCRs trigger a Ca2+ signal by activating PLCβ
via the active Gαq subunit or Gβγ complex released by receptors that
activate Gαi [35]. Increased cytosolic Ca2+ levels are then stabilized by
activation of Ca2+ pumps in the ER (sarco/endoplasmic reticulum
Ca2+ ATPase, SERCA) and the plasma membrane (plasma membrane
Ca2+ ATPase, PMCA), which remove Ca2+ from the cytosol [35]. Previ-
ously, it was reported that activation of NFAT-dependent transcription
by KSHV vGPCR is partially inhibited by the PLC inhibitor, U-73122, in
293T cells [36]. In addition, Gαi and Gαq-coupled ERK1/2 pathways
partially contribute to NFAT activation, as measured by speciﬁc inhibi-
tors, in primary effusion lymphoma (PEL) cells expressing KSHV
vGPCR [25]. However, Zhang et al. recently showed that KSHV vGPCR-
induced NFAT activation is resistant to another PLC inhibitor, adelfosine,
and an IP3R inhibitor, 2-aminoethoxydiphenyl borate (2-APB), in 293T
cells [9]. Instead, the vGPCR physically interactswith SERCA and inhibits
its ATPase activity, thereby increasing cytosolic Ca2+ concentration and
potentiating NFAT activation [9]. They also showed that cyclosporine A,
a calcineurin inhibitor, treatment diminishedNFAT-dependent gene ex-
pression and tumor formation induced by viral GPCRs in vivo, indicating
that NFAT activation is essential in vGPCR-mediated tumorigenesis [9].
Consistent with this, we observed PLC-β activation as well as elevation
of cytosolic Ca2+ levels in cells expressingHVS vGPCR (Fig. 1). Although
we did not characterize the exactmechanism of howHVS vGPCR persis-
tently activates the NFAT pathway, this might result from the direct ac-
tivation of PLC-β or by inhibition of SERCA as with KSHV vGPCR [9].
The persistent activation of cellular signaling as well as transcrip-
tional activation of NFAT and AP-1 by HVS vGPCR results in activation
of T cells as measured by enhanced surface expression of activation
markers, CD69 and CD25, as well as by IL-2 secretion. In a previous
study that used a transgenic mouse model, CD2 promoter-driven ex-
pression of KSHV vGPCR in T cells induced angioproliferative lesions
similar to human KS, potentially via an indirect and paracrine mecha-
nism, although the phenotypes of cells expressing vGPCR were poorly
deﬁned [5]. In this study, we found that HVS vGPCR can activate Jurkat
cells as well as primary human T cells. Interestingly, cellular activation
is independent of cognate TCR signaling molecules, such as TCRβ, Lck,
and ZAP70, but dependent on a chemokine receptor, CXCR4. The poten-
tial role of CXCR4 in T cell activation andmodulation has been proposed
by several studies [37–40]. Upon SDF-1, a cognate ligand of CXCR4,
stimulation, CXCR4 physically interacts with TCR and utilizes the
ZAP70-dependent pathway as well as the Gα13-RhoA pathway for co-
stimulatory signaling or cellular trafﬁcking [39,41]. SDF-1 signaling via
the CXCR4-TCR heterodimer uses PLCβ3 to activate the Ras-ERK path-
way and increase intracellular calcium ion concentrations, whereas
PLCγ1 is required for SDF-1-mediated migration via a mechanism
Fig. 7. Inactive mutations in cytoplasmic domain of vGPCR abrogate its interaction with CXCR4. (A) Amino acid sequence of the cytoplasmic tail of HVS vGPCR. (B) Jurkat cells were
electroporated with plasmids encoding wild type vGPCR or the indicated mutants and examined for the surface expression of cellular markers in GFP-positive cells. (C) Surface
expressions of the indicated cellular markers were quantitated from triplicate experiments in Jurkat cells used in (B). Data are presented as the mean + standard deviation. (D) Jurkat
cells were electroporated with plasmids encoding wild type vGPCR or the indicated mutants and examined for the surface expression of cellular markers in GFP-positive cells.
(E) Surface expressions of the indicated cellular markers were quantitated from triplicate experiments in Jurkat cells used in (D). Data are presented as the mean + standard
deviation. (F) 293T cells were transfected with plasmid encoding wild type vGPCR or the indicated mutants, together with a plasmid encoding CXCR4. Cellular lysates were
precipitated with anti-ﬂag antibody (vGPCRs) and applied for immunoblot with indicated antibodies. Relative position of a molecular weight marker is indicated in each immunoblot.
**, p b 0.01 when compared to vector control.
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neous expression and cooperation between CCR5 andCXCR4 are required
for chemokine-induced T cell costimulation at the immunological synap-
se [37]. Therefore, it seems clear that CXCR4 contributes to T cell activa-
tion upon stimulation. In this study, however, we found that T cell
activation by HVS vGPCR is mediated by a physical interaction, i.e.
heteromeric complex formation, with cellular CXCR4 in the absence
of SDF-1 stimulation and is independent of upstream TCR signaling
molecules.
Then, how does the vGPCR and CXCR4 heteromeric complex stimu-
late cellular signaling to induce T cell activation? Crosstalk between
GPCRs has beenwidely recognized to contribute to GPCR-mediated sig-
naling events and functions [38,42–44]. The formation of homo- and/or
hetero-oligomeric complexes among GPCRs opens a new dimension of
possiblemolecular and functional GPCR interactions [38,42]. In addition
to ligand-binding properties, unique allosteric interactions in GPCR
homo- and/or hetero-oligomers may correlate with intrinsic or signal-
ing efﬁcacy [42]. For example, the functional interaction between EBV
vGPCR, BILF1, with cellular GPCRs such as CXCR4 and histamine H4 re-
ceptor, has been reported and constitutively active vGPCRwas shown to
impair CXCR4 signaling upon SDF-1 stimulation by scavenging Gαi pro-
teins [20]. One study also showed that KSHV vGPCR inhibits calcium
mobilization induced by the thyrotropin-releasing hormone receptor
and the muscarinic acetylcholine M1 receptor [45]. Although positiveand negative regulation of cellular GPCRs, especially chemokine recep-
tors, by other herpesviral vGPCRs have been reported in multiple stud-
ies [32], most studies mainly focused on the changes in signaling
efﬁcacy of cellular GPCRs upon ligand stimulation when co-expressed
together with a vGPCR. In this study, we found that constitutive activa-
tion of T cells by HVS and KSHV vGPCRs is substantially abolished by
knock-down of CXCR4, indicating that the interaction of the vGPCRs
with cellular CXCR4 is functionally linked to the constitutive activity of
vGPCR. In addition, functionally inactive vGPCRmutants are also unable
to interact with CXCR4, suggesting that vGPCR function in T cells might
be controlled through the formation of heteromeric vGPCR-CXCR4 com-
plexes. Recently, it was reported that CXCR4 contributes to the function
of theα1-adrenergic receptor (AR), another GPCR, via heteromeric com-
plex formation [38]. Disruption of theα1-AR and CXCR4 heteromer by a
peptide derived from the transmembrane helix 2 of CXCR4 or by CXCR4
knockdown abolished phenylephrine, an agonist of α1-AR, induced cal-
cium mobilization and myosin light chain phosphorylation, thereby
inhibiting contraction of vascular smooth muscle cells uponα1-AR acti-
vation [38]. Interestingly, a CXCR4 antagonist, AMD3100, did not affect
phenylephrine-induced α1-AR function, suggesting that heteromeric
complex formation controls α1-AR function independent of ligand oc-
cupation or the activation status of CXCR4 [38]. Dopamine receptor
subtype-2 was shown to undergo similar phenomenon in a study that
revealed that its function could be modulated by unoccupied ghrelin
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pretreated Jurkat cells with AMD3100, HVS vGPCR expression still acti-
vated T cells, but surface expression of CXCR4was further downregulat-
ed (Supplementary Fig. S11). Therefore, the physical interaction with
CXCR4 might be the primary requisite for the constitutive activity of
HVS vGPCR, regardless of ligand occupation or the activation status of
CXCR4. This hypothesis could be further supported by the results show-
ing that all inactive vGPCR mutants examined failed to interact with
CXCR4 (Fig. 6 and 7). Further analysis on the structural basis of the
heteromeric complex needs to be conducted in order to explain how
the speciﬁc amino acid residues mutated in the inactive forms contrib-
ute to heteromeric complex formationwith CXCR4 aswell as vGPCR ac-
tivity. In addition, β-arrestin-mediated signaling, which can activate
MAP kinases, such as ERK1/2 and p38, and AKT pathways [47,48], may
play a role in continuous CXCR4 down-regulation from the cellular sur-
face as well as concomitant signaling activation by vGPCR expression.
However, the role of β-arrestin in vGPCR-mediated signaling remains
to be determined [32].
Considering that CXCR4 is the chemokine receptor most widely
expressed in malignant tumors and plays various roles in cellular
proliferation, angiogenesis, and metastasis [48–50], exploitation of
this chemokine receptor by vGPCR through heteromeric complex
formation could be a novel strategy utilized by oncogenic γ2-
herpesviruses such as KSHV and HVS. In our knowledge, this is the
ﬁrst report showing that a vGPCR potently activates T cells without
involvement of proximal TCR signaling molecules, but in a cellular
CXCR4-dependent manner. The physical contact potentially medi-
ates allosteric interaction between the GPCRs [42,43] and might be
a critical starting point initiating G-protein coupled signaling. Con-
sidering that EBV vGPCR fails to activate T cells, the functional impact
on cellular activation by vGPCRs has been evolutionary conserved
only in γ2-herpesviruses, but not in γ1-herpesviruses. Indeed, geno-
mic location of the genes encoding vGPCRs in γ2-herpesviruses is
conserved in orf74, whereas EBV gene, bilf1, encoding vGPCR is in a
different position. KSHV and HVS vGPCR is homologous to cellular
CXCR2 and might play more signiﬁcant role in modulating cellular
proliferation, but EBV vGPCR is more close to human CXCR4 and pri-
marily involved in evading host immune responses by downregulat-
ing the surfaceMHC class I molecules and suppressing PKR [32]. Even
though potential role of HVS vGPCR in viral replication or oncogene-
sis in vivo need to be conﬁrmed by using a mutant virus, our current
ﬁndings on the role of activation in host T cells provide valuable in-
sight into the mechanisms controlling host cell signaling via inter-
molecular interactions between GPCRs.
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